Literature DB >> 8665557

Levodopa does not aggravate postural tremor in Parkinson's disease.

J Kulisevsky1, A Avila, M Barbanoj, R Antonijoan, J Torres, R Arcelus.   

Abstract

Characterization of postural tremor in Parkinson's disease (PD) is incomplete. It was suggested to be an exaggerated physiological tremor and to be enhanced by the action of levodopa. We compared the magnitude of postural tremor to the magnitude of rest tremor and to plasma levodopa levels in 20 PD patients, 10 with stable motor response to oral levodopa, and 10 with the wearing-off phenomenon. Tremor assessment included motor scores of the Unified Parkinson's Disease Rating Scale and accelerometric measurements. Accelerometric data showed that the absolute power of both rest and postural basal dominant tremor frequencies significantly diminished with the increase in plasma levodopa levels and increased with their decrease. Tremor frequencies were also significantly changed by levodopa, which slowed rest tremor and increased postural tremor dominant frequency. This latter, however, did not reach the 8- to 12-Hz frequency band said to be typical of exaggerated physiological tremor. No significant differences between groups were found in their tremor response to levodopa. This study shows that the net postural tremor exhibited by PD patients is improved by levodopa, that levodopa does not augment tremor in the 8- to 12-Hz range, and that this effect is independent of the patient's motor response pattern of oral levodopa.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8665557     DOI: 10.1097/00002826-199510000-00006

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  1 in total

1.  Quantification of tremor using consumer product accelerometry is feasible in patients with essential tremor and Parkinson's disease: a comparative study.

Authors:  Emilie M J van Brummelen; Dimitrios Ziagkos; Wadim M I de Boon; Ellen P Hart; Robert J Doll; Teppo Huttunen; Petteri Kolehmainen; Geert Jan Groeneveld
Journal:  J Clin Mov Disord       Date:  2020-04-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.